These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 17966559

  • 1. Revision of the requirements for live vaccine processing. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Oct 18; 72(201):59000-3. PubMed ID: 17966559
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Dec 12; 65(239):77497-9. PubMed ID: 11503726
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amendment to examination and investigation sample requirements--FDA. Direct final rule.
    Fed Regist; 1998 Sep 25; 63(186):51297-9. PubMed ID: 10185810
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 1999 May 14; 64(93):26282-7. PubMed ID: 10558530
    [Abstract] [Full Text] [Related]

  • 11. Medical devices; medical device reporting; baseline reports. Direct final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2008 Jun 13; 73(115):33692-5. PubMed ID: 18677824
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); companion document to direct final rule. Food and Drug Administration, HHS. Proposed rule.
    Fed Regist; 1999 May 14; 64(93):26344-8. PubMed ID: 10558531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr 27; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [Abstract] [Full Text] [Related]

  • 17. Investigational new drug applications; clinical holds--FDA. Direct final rule.
    Fed Regist; 1998 Dec 14; 63(239):68676-8. PubMed ID: 10187558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Revision of the requirements for live vaccine processing; confirmation of effective date. Direct final rule; confirmation of effective date.
    Food and Drug Administration, HHS.
    Fed Regist; 2008 Mar 07; 73(46):12262-3. PubMed ID: 18464339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.